This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of John Mcintosh
Introduction
John Mcintosh is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of synthetic pathways, particularly with his recent patent. His work is associated with Merck Sharp & Dohme LLC, a leading pharmaceutical company.
Latest Patents
John Mcintosh holds a patent for a "Novel Synthetic Pathway to Belzutifan." This innovative approach showcases his expertise in developing new methodologies that can potentially enhance therapeutic options in medicine. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge.
Career Highlights
Throughout his career, John has demonstrated a strong dedication to research and development. His role at Merck Sharp & Dohme LLC has allowed him to work on cutting-edge projects that aim to improve patient outcomes. His contributions are vital in the ongoing quest for new treatments.
Collaborations
John Mcintosh has collaborated with talented individuals such as Daniel A Dirocco and Jackson Kenai Blender Cahn. These partnerships highlight the importance of teamwork in the innovation process, as diverse perspectives often lead to groundbreaking discoveries.
Conclusion
John Mcintosh is a prominent figure in the field of synthetic pathways, with a focus on developing innovative solutions in medicine. His work at Merck Sharp & Dohme LLC and his patent for a novel synthetic pathway to Belzutifan exemplify his contributions to the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile